If you are searching for a brain tumor specialist to provide you with a second opinion or suggest a treatment plan that’s appropriate for your specific diagnosis, visit Moffitt Cancer Center. Our Neuro-Oncology program features physicians from a range of specialties who focus exclusively on the evaluation, diagnosis and treatment of primary and metastasized brain cancers.
The multispecialty team of Moffitt’s brain cancer program includes:
• Medical oncologists
• Radiation oncologists
• Other experts
Our diverse and highly experienced team of specialists provides chemotherapy, radiation therapy, biological therapy, immunotherapy, surgical procedures and other treatments for brain cancer in one convenient location. Every patient in this program receives an individualized treatment plan that is developed by our tumor board to ensure the best possible outcomes and quality of life.
"We provide highly coordinated care where patients can see multiple specialists, often during the same appointment. "- Dr. Michael Vogelbaum, Program Leader, Department of Neuro-Oncology and Chief of Neurosurgery
Moffitt also spearheads research initiatives to better understand the role of genetics in brain tumor growth and develop more effective treatment methods. In fact, our robust clinical trials program allows brain cancer patients to experience the latest breakthroughs in treatment before they are made available elsewhere. Our commitment to cancer research has earned us recognition as a National Cancer Institute-designated Comprehensive Cancer Center –the only one based in Florida.
At Moffitt, we understand that brain tumors and brain cancer are more than a disease – it’s an overwhelming diagnosis that warrants emotional support in addition to treatment from a brain tumor specialist. That’s why we offer a full spectrum of supportive care to patients and their families at the same location as our other treatments. Patients are cared for by counselors, dietitians, social workers and other professionals who can help manage side effects of treatment and disease to improve quality of life.
Medically Reviewed by Dr. Michael Vogelbaum, Program Leader, Department of Neuro-Oncology and Chief of Neurosurgery.